<?xml version="1.0" encoding="UTF-8"?>
<p id="p0235">To overcome these bottlenecks, finding clinical trial sites and experienced NRAs that can act as credible authorities is essential, and early discussions need to occur in tandem to development and production to avoid delays.</p>
